Skip to content
thestock.space

On 6 Nov 2026, Kronox Lab Sciences was priced at ₹194.32, or 25.1× trailing earnings, against an industry P/E of 22.1×, and the shares are 15% below their 52-week high. Sales and net profit grew 1.9% and 19% a year over 3 years; its ROCE of 32% is the highest among the 7 largest Specialty Chemicals peers. It carries very little debt, and its dividend yield is 0.3%. It is a small-cap company with a market cap of ₹721 Cr, ranked 88th of 204 Specialty Chemicals companies by market cap; the shares rose 32% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹190.05
Day high
₹195.50
Day low
₹185.62
Prev. close
₹195.38
Volume
30.4K

Health check

2 good · 3 fair · 1 to check
  • ReturnsAhead

    +32.4% over a year, better than 5 of 7 peers.

  • Price tagIn line

    P/E 25.1 vs industry 22.1.

  • GrowthSteady

    Sales +1.9%, profit +18.5% a year over 3 years.

  • ProfitabilityStrong

    ROCE 31.9% vs peer median 24.4%.

  • Balance sheetFair

    Practically debt-free, Piotroski 5 of 9.

  • Red flags1 to check

    Promoter stake down from 74.2% to 64.3%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹721 Cr, #88 of 204 in its industry by size.

Moves with the market

Beta 0.97 vs the NIFTY 50: tracks the market closely.

Key metrics

Last 12 months to Jun 2026: sales ₹105 Cr · profit ₹29 Cr
Market cap
₹721 Cr
Small cap
P/E
25.1
Industry 22.1
Price to book
6.21
Peers 13.33
Dividend yield
0.26%
ROE
26.8%
Peers 23.0%
ROCE
31.9%
Peers 24.4%
Debt to equity
0.01
Debt ₹1.61 Cr
EPS (TTM)
₹7.73
Face value ₹10
OPM (TTM)
33.4%
Net margin 27.2%
Sales growth
+16.9%
Latest quarter vs a year ago
Profit growth
+16.3%
Latest quarter vs a year ago
Price to sales
6.85
EV/EBITDA 18.7

Strengths and risks

Strengths

  • Return on equity of 26.8%.
  • Return on capital employed of 31.9%.
  • Practically debt-free.
  • Quarterly sales up 16.9% on a year ago.
  • Net margin of 27.2%.

Risks to check

  • Promoter stake down from 74.2% to 64.3%.

Derived automatically from reported figures. Not a recommendation.

About Kronox Lab Sciences

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates,…

Headquarters
Vadodara
Sector
Basic Materials
ISIN
INE0ATZ01017
Website
kronoxlabsciences.com

Price range

52 weeks

₹96.00₹227.74

Today

₹185.62₹195.50
Avg volume (3M)
6.6 L
1-year return
plus 32.4%
From 52-week high
minus 14.7%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
KRONOXKronox Lab Sciences194.32minus 0.54%72125.119.431.9%33.4%0.011.9%plus 32.4%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
24.325.525.326.128.4
16.316.917.216.619.4
88.689.59
32.8%33.9%31.7%36.4%31.7%
0.911.12.11.3
–0000
0.40.50.50.70.5
8.49.28.6119.8
25.6%27.3%23.4%27.1%25.6%
6.36.76.687.3
1.701.821.792.162.00

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+1.9%
Profit CAGR 3Y
+18.5%
EPS CAGR 3Y
+18.7%
ROE
26.8%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
95.689.9100101
–minus 6.0%+11.5%+1.0%
73.661.266.666.4
2228.733.634.8
23.0%31.9%33.5%34.4%
1.61.22.14.6
0.1––0.1
1.51.31.42
0.30–0
22.328.634.337.3
25.6%25.4%25.7%25.9%
16.621.425.527.7
–+28.5%+19.3%+8.6%
4.485.756.907.50

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
37.137.137.137.1
7.629.25379
–––1.6
9.47.78.79.8
547498.8128
15.926.928.629.6
–0.50.80.9
3.506.418.6
5.614.936.748.7
2931.726.429.7
547498.8128

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
19.717.430.723.9
−5.5−17.3−28.4−23.8
−13.4–−1.9−0.4
0.80.10.4−0.3
−8.4−12.3−3.1−3.3
11.35.127.620.6
––−1.9−1.9

Shareholding pattern

Source: NSE filings
64.3%
promoters
  • Promoters64.26%
  • Public35.74%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202664.26%35.74%minus 9.95
30 Jun 202674.21%25.79%0.00
31 Mar 202674.21%25.79%0.00
31 Dec 202574.21%25.79%0.00
30 Sep 202574.21%25.79%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you